Displaying 623 (all) recruiting clinical trials.
-
A single-center observational study of the natural history and pathogenesis of hidradenitis suppurativa
The purpose of this study is to understand the natural history and progression of Hidradenitis Suppurativa (HS) and other related disorders, and to help us ... -
A 12-week randomized double-blind placebo-controlled trial investigating the effects of levetiracetam in early psychosis
The purpose of this study is to determine whether adding levetiracetam to usual medication treatment improves outcomes in early psychosis by protecting a part of ... -
Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)
The goal of this research study is to understand whether a lottery program implemented for 6 months can improve medication adherence, and consequently, systolic blood ... -
Expanded Access Program for Lorcaserin (Belviq)
The purpose of this extended access program is to provide continued access to lorcaserin for Dravet syndrome and other epilepsy patients who were being treated ... -
A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib (NSC# 748727 IND# 77782) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1(NF1)
The purpose of the study is to find out the safety and efficacy of the drug selumetinib in treating patients with low-grade glioma. We want ... -
A Multicenter Open-Label Extension Study to Assess the Long-Term Safety Tolerability and Efficacy of Bimekizumab in the Treatment of Subjects with Active Psoriatic Arthritis
The purpose of this study is to help us understand how safe, effective and tolerable an investigational new drug called bimekizumab (bye-me-key-zoo-mab) is for a ... -
A PHASE 1 STUDY OF PRE-OPERATIVE CEMIPLIMAB (REGN2810) ADMINISTERED INTRALESIONALLY FOR PATIENTS WITH RECURRENT CUTANEOUS SQUAMOUS CELL CARCINOMA (CSCC)
The main purpose of this study is to determine the safet and tolerability of cemiplimab. Cemiplimab-rwic is only approved by the U.S. Food and ... -
STATINS USE IN INRACEREBRAL HEMORRHAGE PATIENTS (SATURN)
This research is being done to find out if it is better to continue or discontinue statin drugs in people who had a brain hemorrhage ... -
Anticoagulation for Stroke Prevention and Recovery after ICH (ASPIRE)
Survivors of intracerebral hemorrhage (ICH) who have atrial fibrillation (AF) are at high risk for subsequent ischemic stroke. An “ischemic” stroke is an injury to ... -
A Randomized Double-Blind Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Nonalcoholic Steatohepatitis (NASH)
This study will examen whether the investigational drug, tirzepatide, is safe and able to help study participants with nonalcoholic steatohepatitis (NASH). “Investigational” means that the ...